Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7210
+0.0079 (1.11%)
At close: Sep 4, 2026, 4:00 PM EDT
0.7100
-0.0110 (-1.53%)
After-hours: Sep 4, 2026, 4:30 PM EDT

Daré Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.371.030.012.8110-
Revenue Growth
-10429.36%-99.65%-71.92%--
Gross Profit
3.330.730.01-18.83-20.14-0.1
Operating Income
-11.11-13.55-23.45-30.74-31.39-39.07
Net Income
-10.99-13.4-4.05-30.16-30.95-38.7
Earnings Per Share
-0.78-1.20-0.48-4.15-4.39-7.59
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
12.6224.7115.710.4834.6751.67
Total Debt
6.768.056.051.40.490.27
Net Cash (Debt)
5.8516.669.659.0734.1851.4
Net Cash Growth
192.36%72.69%6.33%-73.46%-33.51%1213.79%
Net Cash Per Share
0.411.491.141.254.8510.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.29-9.895.47-38.86-18.09-28.76
Capital Expenditures
-0.46-0.39-0.57-0.63-0.06-0.01
Free Cash Flow
-11.76-10.274.9-39.49-18.15-28.78
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
243.91%71.29%100.00%--201.42%-
Operating Margin
-813.38%-1315.51%-239692.20%-1094.77%-313.86%-
Pretax Margin
-804.37%-1300.66%-41430.90%-1074.17%-309.48%-
Profit Margin
-804.37%-1300.66%-41430.90%-1074.17%-309.48%-
FCF Margin
-860.62%-997.01%50086.97%-1406.26%-181.52%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--5.54---
PS Ratio
8.1726.772774.4510.857.04-